The disulfidptosis-related gene SLC7A11 is proposed to potentially emerge as a new prognostic biomarker for hepatocellular carcinoma (HCC), presenting both opportunities and challenges for the development of personalized cancer immunotherapy strategies [19]. The gene discussed is SLC7A11; the disease is hepatocellular carcinoma.